18F-FDG-PET brain imaging may highlight brain metabolic alterations in dysautonomic syndrome after human papilloma virus vaccination
Aim
The aim of this study was to evaluate brain glucose metabolism by means of [18F]-fluoro-deoxygluycose (18F-FDG) PET in a group of patients presenting dysautonomic syndrome after human papilloma virus (HPV) immunization.
Methods
Medical records of patients, referred to the ‘Second Opinion Medical Consulting Network’ Medical Centre (Modena, Italy) diagnosed with dysautonomic syndrome were searched. Inclusion criteria were presence in the medical history of adverse drug reactions following HPV vaccine; a Montreal Cognitive Assessment score
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Brain | Cervical Cancer Vaccine | Drugs & Pharmacology | Human Papillomavirus (HPV) | Italy Health | Neurology | Nuclear Medicine | Study | Vaccines